Structure Therapeutics Ownership | Who Owns Structure Therapeutics?


OverviewForecastFinancialsChart

Structure Therapeutics Ownership Summary


Structure Therapeutics is owned by 2.98% institutional investors, 2.74% insiders, and 94.28% retail investors. Deep track capital, lp is the largest institutional shareholder, holding 0.72% of GPCR shares.

GPCR Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockStructure Therapeutics2.98%2.74%94.28%
SectorHealthcare Stocks 279.19%10.62%-189.81%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Deep track capital, lp4.10M0.72%$70.97M
Vestal point capital, lp1.79M0.31%$30.97M
Bvf inc/il1.77M0.31%$30.66M
Ra capital management1.52M0.26%$26.27M
Driehaus capital management1.27M0.22%$22.03M
Tcg crossover management1.06M0.19%$18.40M
Millennium management790.16K0.14%$13.68M
Casdin capital700.00K0.12%$12.12M
Orbimed advisors652.03K0.11%$11.29M
Foresite capital management vi420.00K0.07%$7.27M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Foresite capital management vi420.00K3.98%$7.27M
Tcg crossover management1.06M2.51%$18.40M
Deep track capital, lp4.10M2.30%$70.97M
Vestal point capital, lp1.79M2.21%$30.97M
Exome asset management102.94K1.58%$1.78M
Bvf inc/il1.77M1.25%$30.66M
Casdin capital700.00K0.99%$12.12M
Silverarc capital management188.07K0.67%$3.26M
Monashee investment management292.86K0.60%$5.07M
Ikarian capital264.08K0.56%$4.57M

Top Buyers

HolderShares% AssetsChange
Deep track capital, lp4.10M2.30%1.30M
Monashee investment management292.86K0.60%160.86K
Vestal point capital, lp1.79M2.21%63.99K
Cubist systematic strategies54.82K0.01%54.82K
Pfm health sciences, lp40.40K0.05%40.40K

Top Sellers

HolderShares% AssetsChange
Driehaus capital management1.27M0.21%-784.67K
Ensign peak advisors---308.24K
First light asset management132.38K0.26%-266.48K
Superstring capital management lp---216.81K
Alliancebernstein---142.82K

New Positions

HolderShares% AssetsChangeValue
Cubist systematic strategies54.82K0.01%54.82K$948.87K
Pfm health sciences, lp40.40K0.05%40.40K$699.32K

Sold Out

HolderChange
Fairfield financial advisors-59.00
Clear street markets-246.00
Jefferies financial group-2.00K
Virtus etf advisers-2.24K
Vestcor-4.70K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202532-82.32%17,076,259-71.82%20.20%11-88.17%8-82.98%
Dec 31, 20241844.55%60,629,867-1.30%382.54%94-2.08%4928.95%
Sep 30, 2024176-9.28%61,427,3263.62%3821.50%96-22.58%38-2.56%
Jun 30, 202419434.72%59,282,74835.85%1313.72%12461.04%398.33%
Mar 31, 20241444.35%43,639,5912.47%910.61%77-16.30%3644.00%

Recent Insider Transactions


DateNameRoleActivityValue
Feb 06, 2025FMR LLC See Remark 1Sell-
Jun 10, 2024Stevens Raymond C CHIEF EXECUTIVE OFFICERSell-
Jun 03, 2024Lin Xichen CHIEF SCIENTIFIC OFFICERSell-
Jun 03, 2024Lin Xichen CHIEF SCIENTIFIC OFFICERSell-
Mar 14, 2024FMR LLC See Remark 1Sell-

Insider Transactions Trends


DateBuySell
2024 Q3--
2024 Q2-3
2024 Q1-2
2023 Q4-4
2023 Q3--

GPCR Ownership FAQ


Who Owns Structure Therapeutics?

Structure Therapeutics shareholders are primarily institutional investors at 2.98%, followed by 2.74% insiders and 94.28% retail investors. The average institutional ownership in Structure Therapeutics's industry, Biotech Stocks , is 63.96%, which Structure Therapeutics falls below.

Who owns the most shares of Structure Therapeutics?

Structure Therapeutics’s largest shareholders are Deep track capital, lp (4.1M shares, 0.72%), Vestal point capital, lp (1.79M shares, 0.31%), and Bvf inc/il (1.77M shares, 0.31%). Together, they hold 1.34% of Structure Therapeutics’s total shares outstanding.

Does Blackrock own Structure Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Structure Therapeutics.

Who is Structure Therapeutics’s biggest shareholder by percentage of total assets invested?

Foresite capital management vi is Structure Therapeutics’s biggest shareholder by percentage of total assets invested, with 3.98% of its assets in 420K Structure Therapeutics shares, valued at 7.27M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools